Current Environment: Production

Deborah K. VanderVeen | Education

Undergraduate School

Kansas State University

1985, Manhattan, KS

Medical School

University of Kansas Medical Center

1993, Kansas City, KS

Internship

University of Kansas Medical Center

1994, Kansas City, KS

Residency

Boston University Medical School

1997, Boston, MA

Fellowship

Boston Children's Hospital

1998, Boston, MA

Deborah K. VanderVeen | Certifications

  • American Board of Ophthalmology (General)

Deborah K. VanderVeen | Media

Caregiver Profile

Meet Dr. Deborah VanderVeen

Deborah K. VanderVeen | Publications

  1. Timing of Retinopathy of Prematurity Diagnosis and Treatment in Micro-Premature and Nano-Premature Infants During Inpatient Screening. Ophthalmol Retina. 2025 May 23. View Timing of Retinopathy of Prematurity Diagnosis and Treatment in Micro-Premature and Nano-Premature Infants During Inpatient Screening. Abstract

  2. Reply. Ophthalmol Retina. 2025 Apr 16. View Reply. Abstract

  3. Factors Associated with Retinal Detachment after Pediatric Cataract Surgery in the IRIS® Registry. Ophthalmology. 2025 Mar 11. View Factors Associated with Retinal Detachment after Pediatric Cataract Surgery in the IRIS® Registry. Abstract

  4. Visual and refractive outcomes in pediatric Marfan syndrome. J AAPOS. 2025 Apr; 29(2):104175. View Visual and refractive outcomes in pediatric Marfan syndrome. Abstract

  5. Long-term outcomes of Ahmed ClearPath in childhood glaucoma: four-year results. J AAPOS. 2025 Apr; 29(2):104172. View Long-term outcomes of Ahmed ClearPath in childhood glaucoma: four-year results. Abstract

  6. Association of neighborhood Child Opportunity Index with visual outcomes in children with unilateral pediatric cataract. J AAPOS. 2025 Feb; 29(1):104104. View Association of neighborhood Child Opportunity Index with visual outcomes in children with unilateral pediatric cataract. Abstract

  7. Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort. Ophthalmology. 2025 Jun; 132(6):713-717. View Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort. Abstract

  8. Refractive Change at 5 Years in the Toddler Aphakia and Pseudophakia Study. Ophthalmology. 2025 May; 132(5):610-616. View Refractive Change at 5 Years in the Toddler Aphakia and Pseudophakia Study. Abstract

  9. Distribution of Port-Wine Birthmarks and Glaucoma Outcomes in Sturge-Weber Syndrome. Ophthalmol Glaucoma. 2025 Mar-Apr; 8(2):181-187. View Distribution of Port-Wine Birthmarks and Glaucoma Outcomes in Sturge-Weber Syndrome. Abstract

  10. Large language models: a new frontier in paediatric cataract patient education. Br J Ophthalmol. 2024 Sep 20; 108(10):1470-1476. View Large language models: a new frontier in paediatric cataract patient education. Abstract

  11. Validation of the "TWO-ROP" Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center. Ophthalmol Retina. 2025 Jan; 9(1):63-68. View Validation of the "TWO-ROP" Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center. Abstract

  12. Continuous Wave Transscleral Cyclophotocoagulation and Endoscopic Cyclophotocoagulation in Childhood Glaucoma: A Meta-Analysis. J Glaucoma. 2024 Jun 01; 33(6):456-463. View Continuous Wave Transscleral Cyclophotocoagulation and Endoscopic Cyclophotocoagulation in Childhood Glaucoma: A Meta-Analysis. Abstract

  13. Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation. Am J Ophthalmol. 2024 05; 261:1-6. View Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation. Abstract

  14. Identification of pathogenic genetic variants in patients with acquired early-onset bilateral cataracts using next-generation sequencing. J AAPOS. 2024 02; 28(1):103808. View Identification of pathogenic genetic variants in patients with acquired early-onset bilateral cataracts using next-generation sequencing. Abstract

  15. Timing of Diagnosis and Treatment of Glaucoma following Infantile Cataract Surgery. Ophthalmol Glaucoma. 2024 May-Jun; 7(3):290-297. View Timing of Diagnosis and Treatment of Glaucoma following Infantile Cataract Surgery. Abstract

  16. Risk Factors for Glaucoma Diagnosis and Surgical Intervention following Pediatric Cataract Surgery in the IRIS® Registry. Ophthalmol Glaucoma. 2024 Mar-Apr; 7(2):131-138. View Risk Factors for Glaucoma Diagnosis and Surgical Intervention following Pediatric Cataract Surgery in the IRIS® Registry. Abstract

  17. Bevacizumab as adjunctive therapy in anterior persistent fetal vasculature. Eur J Ophthalmol. 2024 Jan; 34(1):NP18-NP21. View Bevacizumab as adjunctive therapy in anterior persistent fetal vasculature. Abstract

  18. Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis. J AAPOS. 2023 08; 27(4):208-211. View Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis. Abstract

  19. Association of Neighborhood Environment with the Outcomes of Childhood Glaucoma. Ophthalmol Glaucoma. 2023 Nov-Dec; 6(6):636-641. View Association of Neighborhood Environment with the Outcomes of Childhood Glaucoma. Abstract

  20. Comparison of baseline biometry measures in eyes with pediatric cataract to age-matched controls. Graefes Arch Clin Exp Ophthalmol. 2023 Oct; 261(10):3007-3013. View Comparison of baseline biometry measures in eyes with pediatric cataract to age-matched controls. Abstract

  21. Ahmed and Baerveldt Glaucoma Drainage Devices in Childhood Glaucoma: A Meta-Analysis. J Glaucoma. 2023 Aug 01; 32(8):686-694. View Ahmed and Baerveldt Glaucoma Drainage Devices in Childhood Glaucoma: A Meta-Analysis. Abstract

  22. Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser. Am J Ophthalmol. 2023 08; 252:275-285. View Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser. Abstract

  23. Axial length and corneal curvature of normal eyes in the first decade of life. Eur J Ophthalmol. 2023 Nov; 33(6):2217-2221. View Axial length and corneal curvature of normal eyes in the first decade of life. Abstract

  24. Social Conditions and the Rate of Severe Retinopathy of Prematurity Among a Diverse Cohort of Infants. JAMA Ophthalmol. 2023 01 01; 141(1):104. View Social Conditions and the Rate of Severe Retinopathy of Prematurity Among a Diverse Cohort of Infants. Abstract

  25. Controversies in Pediatric Angle Surgery and Secondary Surgical Treatment. Semin Ophthalmol. 2023 Apr; 38(3):248-254. View Controversies in Pediatric Angle Surgery and Secondary Surgical Treatment. Abstract

  26. The contribution of intraocular lens calculation accuracy to the refractive error predicted at 10 years in the Infant Aphakia Treatment Study. J AAPOS. 2022 12; 26(6):294.e1-294.e5. View The contribution of intraocular lens calculation accuracy to the refractive error predicted at 10 years in the Infant Aphakia Treatment Study. Abstract

  27. Systemic and ocular associations in pediatric patients undergoing cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2023 Jan; 261(1):241-246. View Systemic and ocular associations in pediatric patients undergoing cataract surgery. Abstract

  28. Effective lens position and pseudophakic refraction prediction error at 10½ years of age in the Infant Aphakia Treatment Study. J AAPOS. 2022 08; 26(4):172.e1-172.e5. View Effective lens position and pseudophakic refraction prediction error at 10½ years of age in the Infant Aphakia Treatment Study. Abstract

  29. Long-term strabismus outcomes after unilateral infantile cataract surgery in the Infant Aphakia Treatment Study. J AAPOS. 2022 08; 26(4):174.e1-174.e4. View Long-term strabismus outcomes after unilateral infantile cataract surgery in the Infant Aphakia Treatment Study. Abstract

  30. Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology. 2022 10; 129(10):1120-1128. View Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Abstract

  31. The accuracy of intraocular lens calculation varies by age in the Infant Aphakia Treatment Study. J AAPOS. 2022 06; 26(3):143-145. View The accuracy of intraocular lens calculation varies by age in the Infant Aphakia Treatment Study. Abstract

  32. Myopic Shift at 10-Year Follow-up in the Infant Aphakia Treatment Study. Ophthalmology. 2022 09; 129(9):1064-1065. View Myopic Shift at 10-Year Follow-up in the Infant Aphakia Treatment Study. Abstract

  33. Etiology and outcomes of childhood glaucoma at a tertiary referral center. J AAPOS. 2022 06; 26(3):117.e1-117.e6. View Etiology and outcomes of childhood glaucoma at a tertiary referral center. Abstract

  34. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Am J Ophthalmol. 2022 08; 240:252-259. View Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Abstract

  35. Deviations From Age-Adjusted Normative Biometry Measures in Children Undergoing Cataract Surgery: Implications for Postoperative Target Refraction and IOL Power Selection. Am J Ophthalmol. 2022 07; 239:190-201. View Deviations From Age-Adjusted Normative Biometry Measures in Children Undergoing Cataract Surgery: Implications for Postoperative Target Refraction and IOL Power Selection. Abstract

  36. Long-term outcomes of secondary intraocular lens implantation in children. Graefes Arch Clin Exp Ophthalmol. 2022 May; 260(5):1733-1739. View Long-term outcomes of secondary intraocular lens implantation in children. Abstract

  37. Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022 01; 129(1):100-109. View Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Abstract

  38. Early Experience With Ahmed Clear Path Glaucoma Drainage Device in Childhood Glaucoma. J Glaucoma. 2021 07 01; 30(7):575-578. View Early Experience With Ahmed Clear Path Glaucoma Drainage Device in Childhood Glaucoma. Abstract

  39. Optical coherence tomography in the setting of optic nerve head cupping reversal in secondary childhood glaucoma. J AAPOS. 2021 08; 25(4):236-239. View Optical coherence tomography in the setting of optic nerve head cupping reversal in secondary childhood glaucoma. Abstract

  40. Retinopathy of prematurity screening and risk mitigation during the COVID-19 pandemic. J AAPOS. 2021 04; 25(2):91.e1-91.e5. View Retinopathy of prematurity screening and risk mitigation during the COVID-19 pandemic. Abstract

  41. Impact of higher oxygen saturation levels on postnatal weight gain to predict retinopathy of prematurity. Acta Paediatr. 2021 08; 110(8):2348-2349. View Impact of higher oxygen saturation levels on postnatal weight gain to predict retinopathy of prematurity. Abstract

  42. Machine Learning Applications in Pediatric Ophthalmology. Semin Ophthalmol. 2021 May 19; 36(4):210-217. View Machine Learning Applications in Pediatric Ophthalmology. Abstract

  43. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 02 01; 139(2):165-173. View Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. Abstract

  44. Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study. J Cataract Refract Surg. 2021 02 01; 47(2):172-177. View Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study. Abstract

  45. Autosomal-dominant WFS1-related disorder-Report of a novel WFS1 variant and review of the phenotypic spectrum of autosomal recessive and dominant forms. Am J Med Genet A. 2021 02; 185(2):528-533. View Autosomal-dominant WFS1-related disorder-Report of a novel WFS1 variant and review of the phenotypic spectrum of autosomal recessive and dominant forms. Abstract

  46. Workforce Shortage for Retinopathy of Prematurity Care and Emerging Role of Telehealth and Artificial Intelligence. Pediatr Clin North Am. 2020 08; 67(4):725-733. View Workforce Shortage for Retinopathy of Prematurity Care and Emerging Role of Telehealth and Artificial Intelligence. Abstract

  47. Outcomes of Bilateral Cataract Surgery in Infants 7 to 24 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry. Ophthalmology. 2021 02; 128(2):302-308. View Outcomes of Bilateral Cataract Surgery in Infants 7 to 24 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry. Abstract

  48. Ocular injury via epinephrine auto-injector. J AAPOS. 2020 06; 24(3):179-181. View Ocular injury via epinephrine auto-injector. Abstract

  49. Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmol. 2020 06 01; 138(6):698-701. View Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity. Abstract

  50. Juvenile cataract in association with tuberous sclerosis complex. Ophthalmic Genet. 2020 08; 41(4):345-349. View Juvenile cataract in association with tuberous sclerosis complex. Abstract

  51. Accuracy of Autorefraction in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 09; 127(9):1259-1267. View Accuracy of Autorefraction in Children: A Report by the American Academy of Ophthalmology. Abstract

  52. Outcomes of Glaucoma Drainage Devices in Childhood Glaucoma. Semin Ophthalmol. 2020 Apr 02; 35(3):194-204. View Outcomes of Glaucoma Drainage Devices in Childhood Glaucoma. Abstract

  53. An ophthalmologist's view on breaking bad news to patients. J AAPOS. 2020 02; 24(1):1.e1-1.e2. View An ophthalmologist's view on breaking bad news to patients. Abstract

  54. Reply. Ophthalmology. 2020 01; 127(1):e8-e9. View Reply. Abstract

  55. Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry. Ophthalmology. 2020 04; 127(4):501-510. View Outcomes of Bilateral Cataracts Removed in Infants 1 to 7 Months of Age Using the Toddler Aphakia and Pseudophakia Treatment Study Registry. Abstract

  56. Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 02; 127(2):261-272. View Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology. Abstract

  57. Reply. Ophthalmology. 2020 01; 127(1):e6-e7. View Reply. Abstract

  58. Early presentation of pigment dispersion syndrome. Can J Ophthalmol. 2020 02; 55(1):e47-e48. View Early presentation of pigment dispersion syndrome. Abstract

  59. Placental CpG Methylation of Inflammation, Angiogenic, and Neurotrophic Genes and Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2019 07 01; 60(8):2888-2894. View Placental CpG Methylation of Inflammation, Angiogenic, and Neurotrophic Genes and Retinopathy of Prematurity. Abstract

  60. Intraocular Lens Implantation during Early Childhood: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 10; 126(10):1454-1461. View Intraocular Lens Implantation during Early Childhood: A Report by the American Academy of Ophthalmology. Abstract

  61. Third-Party Coverage for Aphakic Contact Lenses for Children. Transl Vis Sci Technol. 2019 May; 8(3):41. View Third-Party Coverage for Aphakic Contact Lenses for Children. Abstract

  62. Intraocular Lens Techniques in Pediatric Eyes with Insufficient Capsular Support: Complications and Outcomes. Semin Ophthalmol. 2019; 34(4):293-302. View Intraocular Lens Techniques in Pediatric Eyes with Insufficient Capsular Support: Complications and Outcomes. Abstract

  63. Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity. Semin Perinatol. 2019 10; 43(6):375-380. View Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity. Abstract

  64. Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS). Ophthalmology. 2019 08; 126(8):1189-1195. View Outcomes of Unilateral Cataracts in Infants and Toddlers 7 to 24 Months of Age: Toddler Aphakia and Pseudophakia Study (TAPS). Abstract

  65. Early Postnatal IGF-1 and IGFBP-1 Blood Levels in Extremely Preterm Infants: Relationships with Indicators of Placental Insufficiency and with Systemic Inflammation. Am J Perinatol. 2019 12; 36(14):1442-1452. View Early Postnatal IGF-1 and IGFBP-1 Blood Levels in Extremely Preterm Infants: Relationships with Indicators of Placental Insufficiency and with Systemic Inflammation. Abstract

  66. Use of Orthokeratology for the Prevention of Myopic Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 04; 126(4):623-636. View Use of Orthokeratology for the Prevention of Myopic Progression in Children: A Report by the American Academy of Ophthalmology. Abstract

  67. Global Practice Patterns in the Management of Infantile Cataracts. Eye Contact Lens. 2018 Nov; 44 Suppl 2:S292-S296. View Global Practice Patterns in the Management of Infantile Cataracts. Abstract

  68. Bilateral Immediate Sequential Vitrectomy and Lensectomy for Bilateral Lens Dislocation in Severe Neonatal Marfan Syndrome. Ophthalmic Surg Lasers Imaging Retina. 2018 10 01; 49(10):e151-e153. View Bilateral Immediate Sequential Vitrectomy and Lensectomy for Bilateral Lens Dislocation in Severe Neonatal Marfan Syndrome. Abstract

  69. The Use of ß-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology. Ophthalmology. 2019 01; 126(1):146-155. View The Use of ß-Blockers for the Treatment of Periocular Hemangiomas in Infants: A Report by the American Academy of Ophthalmology. Abstract

  70. Contact Lens Correction of Aphakia in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018 09; 125(9):1452-1458. View Contact Lens Correction of Aphakia in Children: A Report by the American Academy of Ophthalmology. Abstract

  71. Lens regeneration in children. Nature. 2018 04 04; 556(7699):E2-E3. View Lens regeneration in children. Abstract

  72. Weighing in on New Screening Models for Retinopathy of Prematurity. JAMA Ophthalmol. 2018 04 01; 136(4):417-418. View Weighing in on New Screening Models for Retinopathy of Prematurity. Abstract

  73. Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation. Invest Ophthalmol Vis Sci. 2017 12 01; 58(14):6419-6428. View Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation. Abstract

  74. Postoperative Refractive Errors Following Pediatric Cataract Extraction with Intraocular Lens Implantation. Semin Ophthalmol. 2018; 33(1):51-58. View Postoperative Refractive Errors Following Pediatric Cataract Extraction with Intraocular Lens Implantation. Abstract

  75. Response to: 'Unmet needs of cataract blind children in special schools in Southeast Nigeria'. Eye (Lond). 2018 02; 32(2):471. View Response to: 'Unmet needs of cataract blind children in special schools in Southeast Nigeria'. Abstract

  76. Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 12; 124(12):1857-1866. View Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Abstract

  77. Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. JAMA Ophthalmol. 2017 06 01; 135(6):654-656. View Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. Abstract

  78. Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 05; 124(5):619-633. View Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Abstract

  79. Benchmarks for outcome indicators in pediatric cataract surgery. Eye (Lond). 2017 Mar; 31(3):417-421. View Benchmarks for outcome indicators in pediatric cataract surgery. Abstract

  80. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2017 03; 31(3):506-507. View Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Abstract

  81. Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years. J AAPOS. 2016 12; 20(6):501-505. View Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years. Abstract

  82. Treatment of Amblyopia and Amblyopia Risk Factors Based on Current Evidence. Semin Ophthalmol. 2017; 32(1):1-7. View Treatment of Amblyopia and Amblyopia Risk Factors Based on Current Evidence. Abstract

  83. Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study. Ophthalmology. 2016 10; 123(10):2176-82. View Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study. Abstract

  84. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2016 Sep; 30(9):1187-94. View Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Abstract

  85. Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience. Eye (Lond). 2016 Sep; 30(9):1170-4. View Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience. Abstract

  86. Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS). J AAPOS. 2016 Feb; 20(1):49-53. View Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS). Abstract

  87. Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2016 Apr; 123(4):804-16. View Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Abstract

  88. Computer-Assisted Digital Image Analysis of Plus Disease in Retinopathy of Prematurity. Semin Ophthalmol. 2016; 31(1-2):159-62. View Computer-Assisted Digital Image Analysis of Plus Disease in Retinopathy of Prematurity. Abstract

  89. Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates. J Child Neurol. 2016 Mar; 31(4):451-60. View Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates. Abstract

  90. The Specificity of the WINROP Algorithm Can Be Significantly Increased by Reassessment of the WINROP Alarm. Neonatology. 2015; 108(2):152-6. View The Specificity of the WINROP Algorithm Can Be Significantly Increased by Reassessment of the WINROP Alarm. Abstract

  91. Retinoblastoma. Pediatr Clin North Am. 2015 Feb; 62(1):201-23. View Retinoblastoma. Abstract

  92. Eye disorders in newborn infants (excluding retinopathy of prematurity). Arch Dis Child Fetal Neonatal Ed. 2015 May; 100(3):F264-9. View Eye disorders in newborn infants (excluding retinopathy of prematurity). Abstract

  93. Prethreshold retinopathy in premature infants with intrauterine growth restriction. Acta Paediatr. 2015 Jan; 104(1):27-31. View Prethreshold retinopathy in premature infants with intrauterine growth restriction. Abstract

  94. Leukocoria in a 2-year-old boy. J Paediatr Child Health. 2014 Sep; 50(9):744, 747. View Leukocoria in a 2-year-old boy. Abstract

  95. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014 Sep-Nov; 29(5-6):414-20. View Complications of pediatric cataract surgery. Abstract

  96. Complications of intra-arterial chemotherapy for retinoblastoma. Semin Ophthalmol. 2014 Sep-Nov; 29(5-6):429-33. View Complications of intra-arterial chemotherapy for retinoblastoma. Abstract

  97. New insights into the development of infantile intraocular medulloepithelioma. Am J Ophthalmol. 2014 Dec; 158(6):1275-1296.e1. View New insights into the development of infantile intraocular medulloepithelioma. Abstract

  98. Reply: To PMID 24011524. Am J Ophthalmol. 2014 Jun; 157(6):1332-3. View Reply: To PMID 24011524. Abstract

  99. Retinopathy of prematurity and brain damage in the very preterm newborn. J AAPOS. 2014 Jun; 18(3):241-7. View Retinopathy of prematurity and brain damage in the very preterm newborn. Abstract

  100. Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma. JAMA Ophthalmol. 2014 May; 132(5):654. View Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma. Abstract

  101. Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol. 2013 Dec; 156(6):1252-1260.e2. View Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Abstract

  102. Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma. Ophthalmic Surg Lasers Imaging Retina. 2013 Sep-Oct; 44(5):490-2. View Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma. Abstract

  103. Genetics of ectopia lentis. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):313-20. View Genetics of ectopia lentis. Abstract

  104. Corneal endothelial cell characteristics after pediatric cataract surgery. J Pediatr Ophthalmol Strabismus. 2013 Jul-Aug; 50(4):251-4. View Corneal endothelial cell characteristics after pediatric cataract surgery. Abstract

  105. Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. PLoS One. 2013; 8(5):e64325. View Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. Abstract

  106. Congenital glaucoma. J Pediatr. 2013 Jul; 163(1):301. View Congenital glaucoma. Abstract

  107. Uncorrected visual acuity in children with monofocal pseudophakia. J Cataract Refract Surg. 2013 Mar; 39(3):419-24. View Uncorrected visual acuity in children with monofocal pseudophakia. Abstract

  108. One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology. 2013 Jun; 120(6):1227-31. View One-year strabismus outcomes in the Infant Aphakia Treatment Study. Abstract

  109. Relationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataracts. J AAPOS. 2012 Dec; 16(6):554-7. View Relationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataracts. Abstract

  110. Improving preterm ophthalmologic care in the era of accountable care organizations. Arch Ophthalmol. 2012 Nov; 130(11):1433-40. View Improving preterm ophthalmologic care in the era of accountable care organizations. Abstract

  111. Accuracy of intraocular lens power calculation formulae in children less than two years. Am J Ophthalmol. 2012 Oct; 154(4):759-60; author reply 760. View Accuracy of intraocular lens power calculation formulae in children less than two years. Abstract

  112. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012 Aug; 130(8):992-9. View Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Abstract

  113. Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol. 2012 Mar; 130(3):293-9. View Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Abstract

  114. An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis. J Pediatr Hematol Oncol. 2012 Mar; 34(2):e69-71. View An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis. Abstract

  115. Crystalline cataract caused by a heterozygous missense mutation in ?D-crystallin (CRYGD). Mol Vis. 2011; 17:3333-8. View Crystalline cataract caused by a heterozygous missense mutation in ?D-crystallin (CRYGD). Abstract

  116. Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS. 2011 Dec; 15(6):536-40. View Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. Abstract

  117. Secondary intraocular lens implantation after pediatric aphakia. J AAPOS. 2011 Oct; 15(5):435-40. View Secondary intraocular lens implantation after pediatric aphakia. Abstract

  118. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011 Sep 01; 52(10):7052-8. View Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Abstract

  119. Review of the use of digital imaging in retinopathy of prematurity screening. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):214-7. View Review of the use of digital imaging in retinopathy of prematurity screening. Abstract

  120. Technological advances in pediatric cataract surgery. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):271-4. View Technological advances in pediatric cataract surgery. Abstract

  121. Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology. 2011; 99(2):104-11. View Blood gases and retinopathy of prematurity: the ELGAN Study. Abstract

  122. Comparison of intraocular lens power calculation formulae in pediatric eyes. Ophthalmology. 2010 Aug; 117(8):1493-9. View Comparison of intraocular lens power calculation formulae in pediatric eyes. Abstract

  123. Surgical management of infantile cataracts in dystrophic epidermolysis bullosa. J AAPOS. 2010 Jun; 14(3):283-4. View Surgical management of infantile cataracts in dystrophic epidermolysis bullosa. Abstract

  124. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010 Apr; 128(4):443-7. View Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Abstract

  125. Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. J Perinatol. 2010 Nov; 30(11):731-5. View Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. Abstract

  126. Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity. Am J Ophthalmol. 2010 Jul; 150(1):6-9.e2. View Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity. Abstract

  127. Acute periorbital infections: who needs emergent imaging? Pediatrics. 2010 Apr; 125(4):e719-26. View Acute periorbital infections: who needs emergent imaging? Abstract

  128. Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol. 2009 Mar-Apr; 24(2):77-81. View Retinopathy of prematurity: current concepts in molecular pathogenesis. Abstract

  129. Emerging treatments for retinopathy of prematurity. Semin Ophthalmol. 2009 Mar-Apr; 24(2):82-6. View Emerging treatments for retinopathy of prematurity. Abstract

  130. Presentation and management of congenital dacryocystocele. Pediatrics. 2008 Nov; 122(5):e1108-12. View Presentation and management of congenital dacryocystocele. Abstract

  131. Optic nerve sheath fenestration for an isolated optic nerve glioma. J AAPOS. 2009 Feb; 13(1):88-90. View Optic nerve sheath fenestration for an isolated optic nerve glioma. Abstract

  132. Infantile cataracts. Int Ophthalmol Clin. 2008; 48(2):175-92. View Infantile cataracts. Abstract

  133. Cataract update 2008: all you need to know about your pediatric cataract patients. Binocul Vis Strabismus Q. 2008; 23(3):145-58. View Cataract update 2008: all you need to know about your pediatric cataract patients. Abstract

  134. Pediatric endoscopic dacryocystorhinostomy failures: who and why? Laryngoscope. 2007 Feb; 117(2):323-7. View Pediatric endoscopic dacryocystorhinostomy failures: who and why? Abstract

  135. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS. 2006 Oct; 10(5):445-8. View Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. Abstract

  136. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol. 2006 Jun; 124(6):766-73. View Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Abstract

  137. RetCam imaging for retinopathy of prematurity screening. J AAPOS. 2006 Apr; 10(2):107-11. View RetCam imaging for retinopathy of prematurity screening. Abstract

  138. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4734-8. View Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Abstract

  139. Endoscopic dacryocystorhinostomy in children. J AAPOS. 2001 Jun; 5(3):143-7. View Endoscopic dacryocystorhinostomy in children. Abstract

  140. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol. 2001 Apr; 119(4):499-505. View The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Abstract

  141. Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad Sci U S A. 1999 Feb 02; 96(3):1008-12. View Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Abstract

  142. Central retinal vein occlusion in a young child with cyanotic heart disease. Arch Ophthalmol. 1997 Aug; 115(8):1077. View Central retinal vein occlusion in a young child with cyanotic heart disease. Abstract

BESbswy
BESbswy